These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 3274385

  • 21. Mechanism of cyclosporin-induced tolerance to primarily vascularized allografts in miniature swine. Effect of administration of exogenous IL-2.
    Gianello PR, Blancho G, Fishbein JF, Lorf T, Nickeleit V, Vitiello D, Sachs DH.
    J Immunol; 1994 Nov 15; 153(10):4788-97. PubMed ID: 7963544
    [Abstract] [Full Text] [Related]

  • 22. Intrathymic injection of alloantigen may lead to hyperacute rejection and prolonged graft survival of heart allografts in the rat.
    de Bruin RW, van Rossum TJ, Scheringa M, Bonthuis F, IJzermans JN, Marquet RL.
    Transplantation; 1995 Nov 15; 60(9):1061-3. PubMed ID: 7491686
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
    Benvenisty AI, Tannenbaum GA, Cohen DJ, Appel G, Hardy MA.
    Transplant Proc; 1987 Feb 15; 19(1 Pt 3):1889-91. PubMed ID: 3274446
    [No Abstract] [Full Text] [Related]

  • 26. Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients.
    Tellis VA, Matas AJ, Quinn TA, Glicklich D, Weiss RJ, Soberman RJ, Veith FJ.
    Transplant Proc; 1987 Feb 15; 19(1 Pt 3):1892. PubMed ID: 3274447
    [No Abstract] [Full Text] [Related]

  • 27. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
    Barr ML, Cohen DJ, Benvenisty AI, Hardy M, Reemtsma K, Rose EA, Marboe CC, D'Agati V, Suciu-Foca N, Reed E.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):262-4. PubMed ID: 8438294
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG, Huang EH, Bergese SD, Sedmak DD, Birmingham DJ, Ohye RG, VanBuskirk AM.
    J Heart Lung Transplant; 1997 Sep 15; 16(9):889-904. PubMed ID: 9322138
    [Abstract] [Full Text] [Related]

  • 32. Prevention of chronic rejection by cyclosporine and prednisone.
    Arnold AN, Anaise D, Miller F, Waltzer WC, Rapaport FT.
    Transplant Proc; 1987 Feb 15; 19(1 Pt 3):2122-3. PubMed ID: 3274479
    [No Abstract] [Full Text] [Related]

  • 33. One HLA haplo-identical transfusion in first renal allograft recipients: effect on alloimmunisation, acute rejection episodes, and graft survival.
    Bayle F, Masson D, Zaoui P, Janbon B, Bensa JC, Vialtel P.
    Transplant Proc; 1995 Aug 15; 27(4):2457-8. PubMed ID: 7652881
    [No Abstract] [Full Text] [Related]

  • 34. Decreased IFN-gamma and IL-2 mRNA expression in peripheral tolerance to heart allografts with conserved granzyme A, perforin, and MHC antigens mRNA expression.
    Bugeon L, Cuturi MC, Paineau J, Chabannes D, Soulillou JP.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):314-6. PubMed ID: 8438315
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients.
    Tsai EW, Rianthavorn P, Gjertson DW, Wallace WD, Reed EF, Ettenger RB.
    Transplantation; 2006 Dec 27; 82(12):1769-73. PubMed ID: 17198274
    [Abstract] [Full Text] [Related]

  • 38. Clinical and experimental studies with cyclosporine in renal transplantation.
    Kahan BD, van Buren CT, Flechner SM, Jarowenko M, Yasumura T, Rogers AJ, Yoshimura N, LeGrue S, Drath D, Kerman RH.
    Surgery; 1985 Feb 27; 97(2):125-40. PubMed ID: 3881837
    [No Abstract] [Full Text] [Related]

  • 39. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 40. Development of cytotoxic antibodies following renal allograft transplantation is associated with reduced graft survival due to chronic vascular rejection.
    Davenport A, Younie ME, Parsons JE, Klouda PT.
    Nephrol Dial Transplant; 1994 Feb 20; 9(9):1315-9. PubMed ID: 7816298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.